Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6757631 | 0.78 | — | — | |
| SCHEMBL7701521 | 0.78 | — | — | |
| SCHEMBL6319342 | 0.77 | — | — | |
| SCHEMBL1206903 | 0.77 | CYP2D6 (0.36) | CYP2D6CYP2C19 | |
| SCHEMBL7700698 | 0.74 | — | — | |
| SCHEMBL2382567 | 0.70 | CYP2D6 (0.31) | CYP2D6CYP2C19 | |
| SCHEMBL14567551 | 0.69 | CYP2C19 (0.33) | CYP2D6CYP2C19 | |
| Maleic Anhydride SCHEMBL6318484 | 0.67 | CYP2D6 (0.32) | CYP2D6CYP2C19 | |
| SCHEMBL13525789 | 0.66 | CYP2C19 (0.35) | CYP2D6CYP2C19 | |
| SCHEMBL6403313 | 0.66 | KDM4E (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410670-B1 | PHOTOLITHOGRAPHY | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-06-25 | — | — | US | claimed |
| EP-1149826-B1 | Ester compounds having alicyclic structure, and methods for preparing the same | SHINETSU CHEMICAL CO (JP) | 2010-11-24 | — | — | EP | disclosed |
| US-7029822-B2 | Tertiary alcohol compounds having alicyclic structure | SHIN ETSU CHEMICAL CO., LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| EP-1501830-A1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2005-02-02 | — | — | EP | disclosed |
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | HASEGAWA KOJI (JP) | 2004-12-16 | — | — | US | disclosed |
| US-6774258-B2 | USEFUL AS MONOMER TO FORM POLYMER WHICH SERVES AS A BASE RESIN IN CHEMICALLY AMPLIFIED RESIST | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-08-10 | — | — | US | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |
| US-6500961-B2 | MICROSTRUCTURE PATTERNS FOR PHOTORESISTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-6500971-B2 | Ester compounds having alicyclic and oxirane structures and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-6472543-B2 | MONOMERS TO FORM BASSE RESINS FOR USE IN CHEMICALLY AMPLIFIED RESIST COMPOSITIONS ADAPTED FOR MICROPATTERNING LITHOGRAPHY; FIRM ADHESION, HIGH TRANSPARENCY | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-10-29 | — | — | US | disclosed |
| US-6410670-B1 | PHOTOLITHOGRAPHY | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-06-25 | — | — | US | disclosed |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
| US-6403823-B2 | Ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-06-11 | — | — | US | disclosed |
| US-6403822-B2 | NUCLEOPHILIC ADDITION OF ALICYCLIC CARBONYL AND METAL ENOLATE OF ACETATE; POLYCARBON MONOMERS FOR PHOTORESISTS; HIGH REACTIVITY AND SUBSTRATE AFFINITY | SHIN-ETSU CHEMICAL, CO., LTD. (JP) | 2002-06-11 | — | — | US | disclosed |
| US-20020035279-A1 | Novel ester compounds having alicyclic and oxirane structures and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-03-21 | — | — | US | disclosed |
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-14 | — | — | US | disclosed |
| US-20020016477-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-07 | — | — | US | disclosed |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| US-20010051742-A1 | Novel ester compounds having alicyclic structure and method for preparing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-1149826-A2 | Ester compounds having alicyclic structure, and methods for preparing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2001-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016477-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | APH1A, LIMK1, APH1B | CYP2D6 3227/4885CYP2C19 3024/4885 |
| US-20020019545-A1 | Novel lactone compounds having alicyclic structure and their manufacturing method | RACK1, MRPS22, ECH1 | CYP2D6 2295/4885CYP2C19 2790/4885 |
| US-20020035279-A1 | Novel ester compounds having alicyclic and oxirane structures and method for preparing the same | OXER1, OXGR1, ITGA1 | CYP2D6 1409/4885CYP2C19 1926/4885 |
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | CYP2D6 4595/4885CYP2C19 4451/4885 |
| US-20010051742-A1 | Novel ester compounds having alicyclic structure and method for preparing same | ARCN1, ECH1, GAR1 | CYP2D6 2877/4885CYP2C19 3946/4885 |
| US-20010051741-A1 | Novel ester compounds having alicyclic structure and method for preparing same | ARCN1, ECH1, ASIC1 | CYP2D6 2584/4885CYP2C19 3963/4885 |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | CYP2D6 4595/4885CYP2C19 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.